microcapsuled enrofloxacin

Pruduct Name: Microcapsuled Enrofloxacin(10%) Trade Name: Neo-enfx Trademark: Marketing Status: Rx Key Component: Enrofloxacin micropowder (10%); Specific plant-based lipidic coating.

Description: White granule (60±20 mesh) Production Methods: Intelligent Microcapsule Technology (IM) Features: Acid & alkali resistant and hydrophobic Never bitter or irritant in mouth / stomach Sustained released in the small intestine Well mixed with feed because of rough surface Lightproof coating and box avoiding photolysis Pharmacological Action: Just like enrofloxacin powder, Neo-enfx has antibacterial activity against a broad spectrum of gram-negative and gram-positive bacteria as follows: Pseudomonas aeruginosa, Klebsiella spp., Escherichia coli, Enterobacter, Campylobacter, Shigella, Salmonella, Aeromonas, Haemophilus, Proteus, Yersinia, Serratia, Vibrio, Brucella, Chlamydia trachomatis, Mycoplasma, Mycobacterium sp., Staphylococci(including penicillinase-producing and methicillin-resistant strains) Variable activity against: streptococci Ineffective against anaerobes Adverse Reaction: No prescription Indication: Enrofloxacin Premix.

Used to prevent and treat respiratory diseases, septic colibacillosis, malignant rhinitis, pasteurella, salmonellosis, staphylocosis, dysentery, endemic epidemic pneumonia, hydropsy, mastitis and so on.

Usage and Dosage: (eg. pig): Prevention: 0.80~1.0 g/kg feed Treatment: 1.0~1.5 g/kg feed Using for 5 - 7 continuous days Precaution: Do not recommend long-term overuse in piglet to avoid potential cartilage abnormality.

Withdrawal Period: 7 days before the slaughter Content Specification: 100g: 10g Packing: 10kg Storage: Sealed in cool and dry place Validity: 24 months